Tolerance, adherence, and acceptability of a ketogenic 2.5:1 ratio, nutritionally complete, medium chain triglyceride-containing liquid feed in children and adults with drug-resistant epilepsy following a ketogenic diet.
Corbin GriffenNatasha E SchoelerRobert BrowneTracy CameronMartin KirkpatrickSeema ThowfeekJudith MunnHelena ChampionNicole MillsSiân PhillipsLinda AirAnita DevlinClaire NicolSusan MacfarlaneVictoria BittlePhillipa ThomasLisa CookeJulia AckrilAstrid AllfordVanessa AppleyardClare SzwecKiranjit AtwalGary P HubbardRebecca J StrattonPublished in: Epilepsia open (2024)
This study examined the use of a ready-to-use, nutritionally complete, 2.5:1 ratio (2.5 g of fat to 1 g of protein plus carbohydrate) liquid feed, including medium chain triglycerides (MCTs), into a ketogenic diet (KD) in children and adults with drug-resistant epilepsy. The results show that the 2.5:1 ratio feed was well tolerated, adhered to, and accepted in these patients. Increases in MCT intake (particularly C8 and C10) and improvements in seizure outcomes (reduced seizure burden and intensity) and KD adherence also occurred with the 2.5:1 ratio feed in patients with the worst seizures and adherence, respectively.
Keyphrases
- drug resistant
- multidrug resistant
- acinetobacter baumannii
- temporal lobe epilepsy
- young adults
- physical activity
- weight loss
- newly diagnosed
- end stage renal disease
- ejection fraction
- ionic liquid
- glycemic control
- type diabetes
- prognostic factors
- body mass index
- pseudomonas aeruginosa
- fatty acid
- binding protein
- high density